Peapack-Gladstone Financial Corp’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,159
| Closed | -$336K | – | 693 |
|
|
2026
Q1 | $336K | Sell |
11,159
-648
| -5% | -$20.8K | ﹤0.01% | 562 |
|
|
2025
Q4 | $368K | Sell |
11,807
-2,375
| -17% | -$58.5K | ﹤0.01% | 547 |
|
|
2025
Q3 | $286K | Buy |
14,182
+3,782
| +36% | +$66.4K | ﹤0.01% | 589 |
|
|
2025
Q2 | $174K | Buy |
+10,400
| New | +$168K | ﹤0.01% | 651 |
|
|
2025
Q1 | – | Sell |
-10,677
| Closed | -$235K | – | 722 |
|
|
2024
Q4 | $235K | Sell |
10,677
-590
| -5% | -$10.7K | ﹤0.01% | 614 |
|
|
2024
Q3 | $203K | Sell |
11,267
-4,176
| -27% | -$73.1K | ﹤0.01% | 656 |
|
|
2024
Q2 | $251K | Sell |
15,443
-10,720
| -41% | -$165K | ﹤0.01% | 592 |
|
|
2024
Q1 | $369K | Sell |
26,163
-12,827
| -33% | -$162K | 0.01% | 535 |
|
|
2023
Q4 | $407K | Sell |
38,990
-17,518
| -31% | -$164K | 0.01% | 520 |
|
|
2023
Q3 | $576K | Sell |
56,508
-11,791
| -17% | -$110K | 0.01% | 450 |
|
|
2023
Q2 | $514K | Sell |
68,299
-5,411
| -7% | -$43.9K | 0.01% | 478 |
|
|
2023
Q1 | $652K | Sell |
73,710
-5,392
| -7% | -$53.3K | 0.01% | 431 |
|
|
2022
Q4 | $721K | Sell |
79,102
-2,251
| -3% | -$19.6K | 0.01% | 414 |
|
|
2022
Q3 | $657K | Buy |
81,353
+4,071
| +5% | +$36K | 0.01% | 420 |
|
|
2022
Q2 | $581K | Buy |
77,282
+3,106
| +4% | +$27.1K | 0.01% | 425 |
|
|
2022
Q1 | $697K | Buy |
74,176
+16,685
| +29% | +$139K | 0.01% | 416 |
|
|
2021
Q4 | $461K | Buy |
57,491
+7,429
| +15% | +$67.1K | 0.01% | 483 |
|
|
2021
Q3 | $488K | Buy |
50,062
+5,024
| +11% | +$47K | 0.01% | 470 |
|
|
2021
Q2 | $446K | Sell |
45,038
-627
| -1% | -$6.64K | 0.01% | 439 |
|
|
2021
Q1 | $527K | Buy |
+45,665
| New | +$524K | 0.01% | 401 |
|
|
2016
Q1 | – | Sell |
-4,205
| Closed | -$276K | – | 335 |
|
|
2015
Q4 | $276K | Sell |
4,205
-251
| -6% | -$15.5K | 0.02% | 281 |
|
|
2015
Q3 | $252K | Sell |
4,456
-550
| -11% | -$35.7K | 0.02% | 287 |
|
|
2015
Q2 | $296K | Sell |
5,006
-315
| -6% | -$19.4K | 0.02% | 270 |
|
|
2015
Q1 | $331K | Buy |
5,321
+1
| +0% | +$58 | 0.02% | 264 |
|
|
2014
Q4 | $306K | Sell |
5,320
-285
| -5% | -$15.9K | 0.02% | 258 |
|
|
2014
Q3 | $301K | Buy |
5,605
+200
| +4% | +$10.6K | 0.02% | 250 |
|
|
2014
Q2 | $283K | Buy |
5,405
+470
| +10% | +$24K | 0.02% | 256 |
|
|
2014
Q1 | $261K | Sell |
4,935
-700
| -12% | -$32.4K | 0.02% | 265 |
|
|
2013
Q4 | $226K | Sell |
5,635
-40
| -0.7% | -$1.57K | 0.02% | 269 |
|
|
2013
Q3 | $214K | Sell |
5,675
-4,450
| -44% | -$174K | 0.02% | 270 |
|
|
2013
Q2 | $397K | Buy |
+10,125
| New | +$394K | 0.04% | 216 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Peapack-Gladstone Financial Corp's TEVA Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 11,159 shares — an estimated $336K sold.
Peapack-Gladstone Financial Corp first reported a position in TEVA in Q2 2013 and held it in 31 quarters. The position peaked at $721K in Q4 2022. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Peapack-Gladstone Financial Corp reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
- Peapack-Gladstone Financial Corp sold 11,159 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $336K.
- Peapack-Gladstone Financial Corp first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 31 quarters.
- Peapack-Gladstone Financial Corp's Teva Pharmaceutical Industries Limited position peaked at $721K in Q4 2022.
- 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.